Publications by authors named "Aida Emirova"

Claim this Profile
T
The low global warming potential propellant HFA-152a does not induce bronchoconstriction or impair mucociliary clearance.
Michela Salvadori, Dave Singh, Kusum Mathews, Luca Girardello, Mauro Cortellini, Aida Emirova

Pulm Pharmacol Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating the Impact of Hepatic or Renal Impairment on Tanimilast (CHF6001) Pharmacokinetics: Two Open-Label, Parallel-Group, Single-Center Studies.
Annalisa Piccinno, Maria Gloria Pittelli, Deborah Balzano, Elisa Rizzo, Pooja Bellatti, Aida Emirova

Clin Transl Sci· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and absorption, distribution, metabolism and excretion profiling of tanimilast following an intravenous C-microtracer coadministered with an inhaled dose in healthy male individuals.
Michele Bassi, Veronica Puviani, Debora Santoro, Sonia Biondaro, Aida Emirova

Drug Metab Dispos· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tanimilast, A Novel Inhaled Pde4 Inhibitor for the Treatment of Asthma and Chronic Obstructive Pulmonary Disease.
Fabrizio Facchinetti, Maurizio Civelli, Dave Singh, Alberto Papi, Aida Emirova

Front Pharmacol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COPD patients with chronic bronchitis and higher sputum eosinophil counts show increased type-2 and PDE4 gene expression in sputum.
Dave Singh, Michele Bassi, Deborah Balzano, Germano Lucci, Aida Emirova

J Cell Mol Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of CHF6001, a novel inhaled PDE4 inhibitor in COPD: the PIONEER study.
Dave Singh, Aida Emirova, Catherine Francisco, Debora Santoro, Mirco Govoni

Respir Res· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COPD sputum eosinophils: relationship to blood eosinophils and the effect of inhaled PDE4 inhibition.
Dave Singh, Henrik Watz, Kai Michael Beeh, Oliver Kornmann, Brian Leaker, Aida Emirova

Eur Respir J· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sputum and blood transcriptomics characterisation of the inhaled PDE4 inhibitor CHF6001 on top of triple therapy in patients with chronic bronchitis.
Mirco Govoni, Michele Bassi, Stefano Vezzoli, Germano Lucci, Aida Emirova

Respir Res· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD.
Dave Singh, Kai Michael Beeh, Brendan Colgan, Oliver Kornmann, Brian Leaker, Aida Emirova

Respir Res· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-response of an extrafine dry powder inhaler formulation of glycopyrronium bromide: randomized, double-blind, placebo-controlled, dose-ranging study (GlycoNEXT).
Kai M Beeh, Aida Emirova, Hélène Prunier, Debora Santoro, Marie Anna Nandeuil

Int J Chron Obstruct Pulmon Dis· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis